Bausch Health Companies Inc (BHC)
8.695
+0.10
(+1.10%)
USD |
NYSE |
Apr 19, 16:00
8.62
-0.08
(-0.86%)
After-Hours: 20:00
Bausch Health Free Cash Flow (Quarterly): 246.00M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 246.00M |
| September 30, 2023 | 236.00M |
| June 30, 2023 | 175.00M |
| March 31, 2023 | 103.00M |
| December 31, 2022 | 379.00M |
| September 30, 2022 | -1.322B |
| June 30, 2022 | 67.00M |
| March 31, 2022 | -120.00M |
| December 31, 2021 | -59.00M |
| September 30, 2021 | 364.00M |
| June 30, 2021 | 463.00M |
| March 31, 2021 | 375.00M |
| December 31, 2020 | 310.00M |
| September 30, 2020 | 174.00M |
| June 30, 2020 | 129.00M |
| March 31, 2020 | 189.00M |
| December 31, 2019 | 149.00M |
| September 30, 2019 | 432.00M |
| June 30, 2019 | 276.00M |
| March 31, 2019 | 366.00M |
| December 31, 2018 | 255.00M |
| September 30, 2018 | 489.00M |
| June 30, 2018 | 131.00M |
| March 31, 2018 | 391.00M |
| December 31, 2017 | 506.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 442.00M |
| June 30, 2017 | 221.00M |
| March 31, 2017 | 785.00M |
| December 31, 2016 | 450.00M |
| September 30, 2016 | 479.00M |
| June 30, 2016 | 379.00M |
| March 31, 2016 | 488.00M |
| December 31, 2015 | 516.00M |
| September 30, 2015 | 707.00M |
| June 30, 2015 | 354.50M |
| March 31, 2015 | 376.50M |
| December 31, 2014 | 679.00M |
| September 30, 2014 | 504.80M |
| June 30, 2014 | 252.10M |
| March 31, 2014 | 405.10M |
| December 31, 2013 | 184.80M |
| September 30, 2013 | 171.90M |
| June 30, 2013 | 259.80M |
| March 31, 2013 | 240.60M |
| December 31, 2012 | -22.51M |
| September 30, 2012 | 103.45M |
| June 30, 2012 | 240.31M |
| March 31, 2012 | 154.25M |
| December 31, 2011 | 170.51M |
| September 30, 2011 | 151.89M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.322B
Minimum
Sep 2022
463.00M
Maximum
Jun 2021
135.05M
Average
189.00M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6766M |
| Xenon Pharmaceuticals Inc | -35.54M |